Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05137782 · ClinicalTrials.gov registry record · NA

The Science of the Art of Palliative Care

A NA study of Lung Cancer and Advanced Cancer, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT05137782 is a NA study of Lung Cancer and Advanced Cancer that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 7 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05137782, a NA study of Lung Cancer and Advanced Cancer, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.

Interventions

  • OTHER Specialty Palliative Care

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2023-01-03
Est. Completion 2023-11-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT05137782

The ClinicalTrials.gov registry entry for NCT05137782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Specialty Palliative Care is the first listed.

NCT05137782 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05137782 about?

NCT05137782 is a clinical study titled "The Science of the Art of Palliative Care". This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.

What is the current status of trial NCT05137782?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-01-03. Estimated completion is 2023-11-30.

What conditions does trial NCT05137782 study?

This clinical trial studies the following conditions: Lung Cancer, Advanced Cancer, Gastrointestinal Cancer.

What interventions are being tested in trial NCT05137782?

The interventions under investigation include: Specialty Palliative Care (OTHER).

Who is sponsoring clinical trial NCT05137782?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05137782 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.